The Clinical Research Training Center (CRTC) TL1 trainees recently attended the Association for Clinical and Translational Science (ACTS) 2025 conference in Washington, DC. Held from April 14 to April 17, this four-day conference offered our trainees the opportunity to represent not only our program, but also the broader mission of WashU Medicine. In addition to serving as passionate advocates for translational research, they immersed themselves in learning opportunities and connected with peers, mentors, and leaders from across the country.
From scientific sessions to informal networking events, the conference provided a dynamic environment for both professional growth and collaboration. The theme of this year’s ACTS conference was Integrating Data to Power Translation, and our TL1 trainees made the most of their time by participating in the TL1 lunch, Speed Mentoring sessions, and the exciting 3MT (Three Minute Thesis) presentations. These activities provided invaluable opportunities to learn from experts, share their research, and network with leaders in translational science.
Capitol Hill Visit Recap
While in Washington, DC, the TL1 trainees had the incredible opportunity to visit Capitol Hill. As passionate emerging investigators, they met with representatives and Senate staff members to advocate for clinical and translational science and its impact on their communities and patients.
During these meetings, our trainees presented their Impact Profile, based on the Translational Science Benefits Model (TSBM), shared personal stories, and helped educate policymakers on the importance of continued support for medical research.
Furthermore, our trainees invited them to visit WashU to learn more about the vital research taking place within their individual projects and across campus. This advocacy effort was both fun and rewarding, and we are proud of their initiative and commitment to advancing science!
Highlights from the Poster Presentations
Another major highlight of the ACTS conference was the poster presentations on Tuesday and Wednesday. With over 600 presenters to share their posters, our TL1 trainees were among them, engaging in insightful conversations with other trainees, scientists, and directors of training programs from various institutions.
We are thrilled to announce that James McMenimen, MD was awarded the Blue Ribbon for his outstanding poster presentation on baseline lung allograft dysfunction. Congratulations to James and all our TL1 trainees for their dedication, professionalism, and impressive contributions to this year’s conference!
The TL1 Pre- and Postdoctoral Programs offer exceptional opportunities for research training, collaboration, and professional development in clinical and translational science. Learn more about these programs.